Research location
Weston
Ontario, Canada
Advertisement
Research activity in Weston
Ontario, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 34 trials and 34 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Weston
34 linked trials · page 1 of 1Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesNCT04916470 · 2021-06-15 · 1 site observation
COMPLETED
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and ObesityNCT04788511 · 2021-03-16 · 1 site observation
COMPLETED
PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNadaNCT02957409 · 2016-05-20 · 1 site observation
COMPLETED
Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life SettingNCT02690974 · 2016-03-08 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT02257736 · 2014-11-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionNCT02226120 · 2014-10-16 · 1 site observation
COMPLETED
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection FractionNCT01920711 · 2014-07-18 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerNCT00878709 · 2009-07-09 · 1 site observation
COMPLETED
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or AnastrozoleNCT00863655 · 2009-06-03 · 1 site observation
COMPLETED
Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast CancerNCT00703326 · 2008-08-06 · 1 site observation
COMPLETED
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabNCT00625898 · 2008-04-01 · 1 site observation
TERMINATED
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line ChemotherapyNCT00547651 · 2007-09-01 · 1 site observation
COMPLETED
Study of NOV-002 in Combination With Chemotherapy to Treat Lung CancerNCT00347412 · 2006-11-01 · 1 site observation
COMPLETED
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast CancerNCT00347919 · 2006-07-01 · 1 site observation
COMPLETED
Lapatinib for Brain Metastases In ErbB2-Positive Breast CancerNCT00263588 · 2005-12-02 · 1 site observation
COMPLETED
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and DyslipidaemiaNCT00330785 · 2004-10-01 · 1 site observation
COMPLETED
Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung CancerNCT00065182 · 2003-08-14 · 1 site observation
COMPLETED
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)NCT00168857 · 2003-07-09 · 1 site observation
COMPLETED
High Doses of Candesartan Cilexetil on the Reduction of ProteinuriaNCT00242346 · 2003-04-01 · 1 site observation
COMPLETED
Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)NCT00442845 · 2003-01-01 · 1 site observation
COMPLETED
PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTNNCT00274599 · 2002-10-09 · 1 site observation
COMPLETED
Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)NCT00095238 · 2002-06-01 · 1 site observation
COMPLETED
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerNCT00050960 · 2002-05-01 · 1 site observation
COMPLETED
OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerNCT00036647 · 2001-11-01 · 1 site observation
COMPLETED
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive AdultsNCT00043927 · 2001-04-01 · 1 site observation
COMPLETED
Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung CancerNCT00006229 · 2000-04-04 · 1 site observation
COMPLETED
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in SituNCT00003857 · 1999-12-01 · 1 site observation
COMPLETED
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast CancerNCT00241449 · 1998-11-01 · 1 site observation
COMPLETED
Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate CancerNCT00003232 · 1997-11-24 · 1 site observation
COMPLETED
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast CancerNCT00003032 · 1997-04-25 · 1 site observation
COMPLETED
Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung CancerNCT00003011 · 1997-01-31 · 1 site observation
COMPLETED
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast CancerNCT00002864 · 1996-09-24 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.